Clinical and radiological evaluation of maxillofacial and otorhinolaryngological manifestations of Hansen's disease
- PMID: 36050504
- PMCID: PMC9436959
- DOI: 10.1038/s41598-022-19072-0
Clinical and radiological evaluation of maxillofacial and otorhinolaryngological manifestations of Hansen's disease
Abstract
To characterize maxillofacial, otorhinolaryngological and oral manifestations of Hansen's disease (HD), we conducted a cross-sectional study in 21 current patients attending the Unidade Básica de Saúde de Jardim América, Espírito Santo, Brazil and 16 former patients resident at Pedro Fontes Hospital using data from computed tomography imaging, rhinoscopy, and oroscopy. Maxillofacial characteristics were compared with 37 controls. Differences in bone alterations across the three groups were determined mainly by severe resorption/atrophy being more frequent in former HD patients, with severe resorption/atrophy of the anterior alveolar process of maxilla in 50.0% (8/16) of former patients, 28.6% (6/21) of current patients and 10.8% (4/37) of controls and of nasal bones and aperture in 31.3% (5/16) of former patients compared with 0/21 current patients and two controls. There were no substantial differences in otorhinolaryngological and oroscopic findings between the two patient groups. HD patients had more tooth loss than the age-matched control group. Maxillofacial, otorhinolaryngological and oroscopic finding scores were strongly correlated only in current HD patients. Correlation between otorhinolaryngological and maxillofacial scores suggests that protocols for HD patient assessment and follow-up could include otorhinolaryngological evaluation, with radiological imaging where necessary, subject to replication of our findings in a larger study.
© 2022. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures






Similar articles
-
Clinical and radiological assessment of rhinomaxillary syndrome in Hansen's disease.Indian J Dermatol Venereol Leprol. 2022 May-Jun;88(4):483-493. doi: 10.25259/IJDVL_1203_20. Indian J Dermatol Venereol Leprol. 2022. PMID: 35138068
-
[Prevalence of dry eye in Hansen's disease patients from a colony hospital in Goiânia, Brazil].Arq Bras Oftalmol. 2005 Jul-Aug;68(4):457-61. doi: 10.1590/s0004-27492005000400008. Epub 2005 Nov 22. Arq Bras Oftalmol. 2005. PMID: 16322829 Portuguese.
-
Hansen's disease and COVID-19 co-infection in Brazil.Int J Dermatol. 2022 Dec;61(12):1506-1510. doi: 10.1111/ijd.16319. Epub 2022 Jul 1. Int J Dermatol. 2022. PMID: 35775153 Free PMC article.
-
Zoonotic risk of Hansen's disease from community contact with wild armadillos: A systematic review and meta-analysis.Zoonoses Public Health. 2021 Mar;68(2):153-164. doi: 10.1111/zph.12783. Epub 2020 Nov 23. Zoonoses Public Health. 2021. PMID: 33226194
-
Hansen's disease (Leprosy): current and future pharmacotherapy and treatment of disease-related immunologic reactions.Pharmacotherapy. 2012 Jan;32(1):27-37. doi: 10.1002/PHAR.1009. Pharmacotherapy. 2012. PMID: 22392826 Review.
Cited by
-
Lepromatous leprosy in Bronze Age Oman: micro-CT provides tools for paleopathology in fragmentary and commingled assemblages.Front Med (Lausanne). 2025 Mar 31;12:1521515. doi: 10.3389/fmed.2025.1521515. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40231081 Free PMC article.
-
Leprosy in skeletons from archaeological sites: A systematic review.PLoS Negl Trop Dis. 2025 Aug 19;19(8):e0013374. doi: 10.1371/journal.pntd.0013374. eCollection 2025 Aug. PLoS Negl Trop Dis. 2025. PMID: 40828789 Free PMC article.
References
-
- Towards Zero Leprosy. Global Leprosy (Hansen’s Disease) Strategy 2021–2030. https://www.who.int/publications/i/item/9789290228509.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical